Skip to content
★ Sign in to follow
濟生

濟生 Stock: price and insider trades · Taiwan

TW·Mcap NT$1.7BHealth Care

濟生: what insiders have been doing

Only a handful of insider records exist for 濟生, the last one from 26 May 2021, too few to describe a trend. These figures are compiled from regulatory filings published by TWSE / TPEx (MOPS). They describe what insiders did and are not a recommendation.

Insider Decl.
2
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 1,481 of 26,911 companies
78.3
score / 100
Value
82
Quality
75
FCF yld10%
Earn yld9.6%
EV/EBITDA6.3x
ROE14%
Gross mgn39%
Net mgn12%
Debt/EBITDA0.2x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

NT$29
Analyst consensus
·
Income statement
RevenueNT$1.4B
Gross profitNT$543.7M39% margin
EBITDANT$281.6M20% margin
Net incomeNT$164.3M13.3% margin
Valuation
PER (trailing)9.2x
P/Book1.2x
Beta0.20
Balance sheet & cash
Market capNT$1.7B
Total debtNT$48.8M
Free Cash FlowNT$180.1M
Debt / Equity1%
Profitability & ownership
ROE14.0%
ROA6.6%
% insiders25.2%
% institutions0.0%
Last declaration on 26 May 2021
Declarations2 total
  • ●
    Related company / holdingExecutives
    €519kest.0MOPS
    781,924 sharesShareTPExTWMOPS:4111:110/05/26:丞奎興業股份有限公司:02vguku
  • ●
    DirectorExecutives
    €63kest.0MOPS
    100,000 sharesShareTPExTWMOPS:4111:105/12/12:戴蘇櫻:19mzahj

2 of 2 declarations

About 濟生

濟生 is a company listed on the XTAI market, specializing in the financial services sector.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations